Pipeline Strikes: Novo Nordisk’s liraglutide rankings in Section III paediatric trial
This week on Pipeline Strikes, we kick off by way of taking a look at Novo Nordisk’s of entirety of a Section III trial of liraglutide in kids elderly underneath 12. In